Questions of the Week

Is Metcash a good buy at these levels? How does RIO propose to fund the US$9.9 billion acquisition of Arcadium Lithium – will there be a share issue? Have the results of the NEXTDC share purchase plan been announced? What do the brokers says about Resmed?

Paul Rickard

October 10, 2024

2 min read

This article is for Switzer Report subscribers

Already a subscriber? Log in to access this article.

Join thousands of subscribers who rely on Australia's most trusted independent investment research.

Expert Stock Picks Weekly buy, hold and sell recommendations from analysts with decades of experience.

Model Portfolios Professionally curated portfolios updated regularly so you always know what to own.

Ask the Experts Submit your investing questions and get answers from Peter Switzer and the team.

Start Your 21-Day Free Trial

No commitment. Cancel anytime. Plans from $35/month.

“Switzer Report has been invaluable for my investment decisions. The expert analysis and stock picks have consistently helped me build wealth with confidence.”

★★★★★ — Michael J., subscriber since 2019

21-day free trial

Cancel anytime, no lock-in

Secure payment via Stripe